drugset / Trial / NCT07863635
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1283 and mRNA-1273 (variant formulations) within the current epidemiological environment
Timeline
- Start
- 2026-10-09
- Primary completion
- 2027-01-09
- Completion
- 2027-01-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mRNA-1273 | Messenger RNA (mRNA) | — | Intramuscular |
| Subject | mRNA-1283 | Messenger RNA (mRNA) | — | Intramuscular |